Mats Wahlstrom has more than 37 years of experience in the healthcare industry, having served as CEO and CFO of large international companies in the renal field. Mats currently serves as Executive Chairman of KMG Capital Partners, LLC, Chairman of Breakout Investment Partners, LLC, Chairman of Caduceus Medical Holdings, Inc., and Chairman of Triomed AB, a medical device company. He also serves as the Lead Director of Coherus Biosciences, Inc., a public biotech company. In addition, he serves on the boards of Alteco Medical AB, a public medical device company, and Circuit Clinical Solutions, Inc., a clinical research company.
Mats has also served as a director of Healthgrades, Inc., Zynex, Inc., and Getinge AB, all public companies in the healthcare industry. From January 2004 through December 2009, Mats served as Co-CEO of Fresenius Medical Care North America, and from November 2002 through December 2009 as President and CEO of Fresenius Medical Services, the largest dialysis provider in the U.S. Prior to joining Fresenius Medical Care in 2002, he held various positions at Gambro AB in Sweden, including 10 years as CEO of Gambro North America and Gambro Healthcare, Inc., as well as CFO and Executive Vice President of the Gambro Group.
